Wilcox Ws
Impact in
-
- Cancer Treatment and Pharmacology
- Cancer Cells and Metastasis
-
- Acute Myeloid Leukemia Research
Papers in
- Oncology 5
- Cancer Treatment and Pharmacology 3
- HER2/EGFR in Cancer Research 2
-
- Synthesis and Characterization of Heterocyclic Compounds 2
- Co-authors
- Skipper He (8 shared papers)Schabel Fm (8 shared papers)Trader Mw (2 shared papers)Griswold Dp (2 shared papers)Laster Wr (3 shared papers)Linda Simpson‐Herren (1 shared paper)
- Journals
- PubMed (10 papers)
In The Last Decade
Wilcox Ws
10 papers receiving 270 citations
Peers
Comparison fields: 5 of 63
- Oncology 156
- Hematology 60
- Modeling and Simulation 23
- Cancer Research 57
- Genetics 38
Countries citing papers authored by Wilcox Ws
This map shows the geographic impact of Wilcox Ws's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wilcox Ws with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wilcox Ws more than expected).
Fields of papers citing papers by Wilcox Ws
This network shows the impact of papers produced by Wilcox Ws. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wilcox Ws. The network helps show where Wilcox Ws may publish in the future.
Co-authors
The 6 scholars most cited alongside Wilcox Ws, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Experimental evaluation of potential anticancer agents. XXI. Scheduling of arabinosylcytosine to take advantage of its S-phase specificity against leukemia cells. | 1967 | 178 |
| 2 | EXPERIMENTAL EVALUATION OF POTENTIAL ANTICANCER AGENTS. XIV. FURTHER STUDY OF CERTAIN BASIC CONCEPTS UNDERLYING CHEMOTHERAPY OF LEUKEMIA. | 1965 | 53 |
| 3 | Experimental evaluation of potenital anticancer agents. XVII. Kinetics of growth and regression after treatment of certain solid tumors. | 1965 | 35 |
| 4 | Experimental evaluation of potential anticancer agents. XIX. Sensitivity of nondividing leukemic cell populations to certain classes of drugs in vivo. | 1965 | 35 |
| 5 | Success and failure in the treatment of solid tumors. I. Effects of cyclophosphamide (NSC-26271) on primary and metastatic plasmacytoma in the hamster. | 1968 | 27 |
| 6 | Experimental evaluation of potential anticancer agents. 28. Effects of therapy on viability and rate of proliferation of leukemic cells in various anatomic sites. | 1965 | 17 |
| 7 | The last surviving cancer cell: the chances of killing it. | 1966 | 12 |
| 8 | Experimental evaluation of potential anticancer agents. XVI. Basic study of effects of certain anticancer agents on kinetic behavior of model bacterial cell populations. | 1965 | 9 |
| 9 | Kinetics of cancer cell kill by chemotherapeutic agents in vivo. | 1967 | 2 |
| 10 | Experimental evaluation of potential anticancer agents. X. A specificity test for distinguishing false positives. | 1963 | 2 |
About Wilcox Ws
Wilcox Ws is a scholar working on Oncology, Organic Chemistry, Molecular Biology, Pharmaceutical Science and Computational Theory and Mathematics, having authored 10 papers that have together received 370 indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (3 papers), Computational Drug Discovery Methods (2 papers), Chemical Reactions and Isotopes (2 papers), Cancer therapeutics and mechanisms (2 papers), Synthesis and Characterization of Heterocyclic Compounds (2 papers), HER2/EGFR in Cancer Research (2 papers), Biochemical and Molecular Research (1 paper) and Lung Cancer Treatments and Mutations (1 paper). The work is most often cited by research in Oncology (156 citations), Hematology (60 citations), Modeling and Simulation (23 citations), Cancer Research (57 citations) and Genetics (38 citations). Frequent co-authors include Skipper He, Schabel Fm, Trader Mw, Griswold Dp, Laster Wr and Linda Simpson‐Herren. Their work appears in journals such as PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.